These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Evidence-based interventional pain medicine according to clinical diagnoses. 18. Painful diabetic polyneuropathy. Pluijms W; Huygen F; Cheng J; Mekhail N; van Kleef M; Van Zundert J; van Dongen R Pain Pract; 2011; 11(2):191-8. PubMed ID: 21199315 [TBL] [Abstract][Full Text] [Related]
14. Where does spinal cord stimulation fit into the international guidelines for refractory painful diabetic neuropathy? a consensus statement. Boulton AJM; Jensen TS; Luecke T; Petersen EA; Pop-Busui R; Taylor RS; Tesfaye S; Vileikyte L; Ziegler D Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110763. PubMed ID: 38245326 [TBL] [Abstract][Full Text] [Related]
15. A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy. Khasbage S; Shukla R; Sharma P; Singh S J Diabetes; 2021 Jul; 13(7):532-541. PubMed ID: 33340245 [TBL] [Abstract][Full Text] [Related]
16. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine. Bellows BK; Nelson RE; Oderda GM; LaFleur J Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy for painful diabetic neuropathy is safe and effective. Saul H; Deeney B; Imison C; Tesfaye S BMJ; 2023 Apr; 381():866. PubMed ID: 37085164 [TBL] [Abstract][Full Text] [Related]
18. Current Strategies for the Management of Painful Diabetic Neuropathy. Staudt MD; Prabhala T; Sheldon BL; Quaranta N; Zakher M; Bhullar R; Pilitsis JG; Argoff CE J Diabetes Sci Technol; 2022 Mar; 16(2):341-352. PubMed ID: 32856490 [TBL] [Abstract][Full Text] [Related]